Bon Natural Life Limited Class A Ordinary Shares (BON) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, BON trades at $1.30 with a market cap of $10.49M and a P/E ratio of 0.00. BON moved +0.00% today. Year to date, BON is -23.72%; over the trailing twelve months it is -14.68%. Its 52-week range spans $1.13 to $73.75. Rallies surfaces BON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bon Natural Life Launches Joint Committee with Tigerbone Group for TCM and Functional Foods: On February 4, 2026 Bon Natural Life entered a Cooperation Framework Agreement with Tigerbone Group to collaborate on traditional Chinese medicine, life sciences research and nutritional functional foods under a new "BON Cooperation and Development Committee." Each company will retain its IP rights while jointly developing new products and technologies.
| Metric | Value |
|---|---|
| Price | $1.30 |
| Market Cap | $10.49M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.75 |
| 52-Week Low | $1.13 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BON analyst coverage data. Average price target: $0.00.